Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].

Pathologie-biologie - 1 Sept 2001

Rey D, Schmitt M P, Hess-Kempf G, Krantz V, Partisani M, Bernard-Henry C, Lang J M

Abstract excerpt

Structured therapeutic interruption (STI) has been offered to HIV-1 infected patients with virological failure (viral load > 1500 copies/mL) of potent antiretroviral therapy (ART) (three or four drugs for at least one year). CD4 lymphocyte count, HIV-1 viral load, clinical status, were assessed every month during STI and after ART reintroduction. Genotype analysis by plasma virus sequencing was done before and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anti-HIV Agents
Share to Antiretroviral Therapy, Highly Active

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to CD4 Lymphocyte Count

Share to Cytomegalovirus Infections

Share to Drug Administration Schedule

Share to Drug Resistance, Viral

Share to Viral Load

Share to Viremia

Source

Identifiers

PMID: 11642019
DOI: 10.1016/s0369-8114(01)00211-5

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Structured therapeutic interruption in patients infected with HIV-1 experiencing a block in their antiretroviral treatment: preliminary results].PMID 11642019Read ↗

No benefit of a structured treatment interruption based on genotypic resistance in heavily pretreated HIV-infected patients.Semantic proximity Read ↗

Persistence of drug-resistant HIV-1 after a structured treatment interruption and its impact on treatment response.Semantic proximity Read ↗

Immunovirologic consequences and safety of short, non-structured interruptions of successful antiretroviral treatment.Semantic proximity Read ↗

Virologic Determinants of Success After Structured Treatment Interruptions of Antiretrovirals in Acute HIV-1 InfectionSemantic proximity Read ↗

Evolution of HIV-1 genotype in plasma RNA and peripheral blood mononuclear cells proviral DNA after interruption and resumption of antiretroviral therapy.Semantic proximity Read ↗

Genotypic resistance tests for the management of structured therapeutic interruptions after multiple drug failure.Semantic proximity Read ↗

Virological and immunological effects of treatment interruptions in HIV-1 infected patients with treatment failure.Semantic proximity Read ↗

Development of HIV with drug resistance after CD4 cell count-guided structured treatment interruptions in patients treated with highly active antiretroviral therapy after dual-nucleoside analogue treatment.Semantic proximity Read ↗

Emergence of drug-resistant HIV-1 variants in patients undergoing structured treatment interruptions.Semantic proximity Read ↗

HIV therapy after treatment interruption in patients with multiple failure and more than 200 CD4+ T lymphocyte count.Semantic proximity Read ↗

HIV-1 natural viral suppressors: control of viral replication in the absence of therapySemantic proximity Read ↗

Cerebrospinal fluid response to structured treatment interruption after virological failure.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.